Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review

Detalhes bibliográficos
Autor(a) principal: Ramôa, Andreia
Data de Publicação: 2018
Outros Autores: Costa, Pedro, Ribeiro, Ana Maria, Castro, Stephanie De
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.32385/rpmgf.v34i2.12400
Resumo: Objective: Maternal supplementation with folic acid has a positive effect on the prevention of neural tube defects. The relationship between high-dose supplementation of folic acid (5mg) and the development of asthma in children is controversial. The aim of this review is to appraise the evidence on the association between the supplementation with high doses of folic acid during pregnancy and the risk of developing asthma in childhood. Data sources: National Guideline Clearinghouse, Canadian Medical Association Practice Guidelines, Cochrane Library, DARE, Bandolier, PubMed and Index of Portuguese Medical Journals. Review method: We searched meta-analyses, systematic reviews, original studies and clinical guidelines published between July/2006 and July/2016 in Portuguese, English, Spanish and French languages, using the MeSH terms: ‘Folic Acid’, ‘Asthma’ and ‘Pregnancy’. The Strength of Recommendation Taxonomy (SORT) scale of the American of Family Physicians was used to assign evidence levels and strength of recommendation grades. Results: Five studies were selected from a total of 29 articles found, including two meta-analyses and three original studies. Results from meta-analyses do not support an association between periconceptional folic acid supplementation and increased risk of developing childhood asthma. However, none of the studies included in the meta-analyses stratified the results according to the dose of folic acid used during pregnancy and risk of asthma. On the other hand, original studies suggest that supplementation with high doses of folic acid during pregnancy may increase the risk of developing asthma in childhood. Conclusions: Evidence on the association between folic acid supplementation during pregnancy and the risk of developing asthma during childhood is controversial. Studies showing results stratified according to the dose of folic acid reveal that high doses (>800mg) are associated with an increased risk of developing childhood asthma (SORT B).
id RCAP_21157b9414c4f3adf95891fc1ec1918e
oai_identifier_str oai:ojs.rpmgf.pt:article/12400
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based reviewSuplementação excessiva com ácido fólico durante a gravidez e desenvolvimento de asma na infância: uma revisão baseada na evidênciaFolic acidAsthmaPregnancyÁcido fólicoAsmaGravidezObjective: Maternal supplementation with folic acid has a positive effect on the prevention of neural tube defects. The relationship between high-dose supplementation of folic acid (5mg) and the development of asthma in children is controversial. The aim of this review is to appraise the evidence on the association between the supplementation with high doses of folic acid during pregnancy and the risk of developing asthma in childhood. Data sources: National Guideline Clearinghouse, Canadian Medical Association Practice Guidelines, Cochrane Library, DARE, Bandolier, PubMed and Index of Portuguese Medical Journals. Review method: We searched meta-analyses, systematic reviews, original studies and clinical guidelines published between July/2006 and July/2016 in Portuguese, English, Spanish and French languages, using the MeSH terms: ‘Folic Acid’, ‘Asthma’ and ‘Pregnancy’. The Strength of Recommendation Taxonomy (SORT) scale of the American of Family Physicians was used to assign evidence levels and strength of recommendation grades. Results: Five studies were selected from a total of 29 articles found, including two meta-analyses and three original studies. Results from meta-analyses do not support an association between periconceptional folic acid supplementation and increased risk of developing childhood asthma. However, none of the studies included in the meta-analyses stratified the results according to the dose of folic acid used during pregnancy and risk of asthma. On the other hand, original studies suggest that supplementation with high doses of folic acid during pregnancy may increase the risk of developing asthma in childhood. Conclusions: Evidence on the association between folic acid supplementation during pregnancy and the risk of developing asthma during childhood is controversial. Studies showing results stratified according to the dose of folic acid reveal that high doses (>800mg) are associated with an increased risk of developing childhood asthma (SORT B).Objetivo: A suplementação materna com ácido fólico tem um efeito positivo na prevenção de defeitos do tubo neural. É controversa a relação entre a suplementação com altas doses de ácido fólico (5mg) e a asma na criança. O objetivo desta revisão é conhecer a evidência da associação entre a suplementação com altas doses de ácido fólico durante a gravidez e o risco de desenvolvimento de asma na infância. Fontes de dados: National Guideline Clearinghouse, Canadian Medical Association Pratice Guidelines, Cochrane Library, DARE, Bandolier, PubMed e Índex de Revistas Médicas Portuguesas. Métodos de revisão: Pesquisa de meta-análises, revisões sistemáticas, estudos originais e normas de orientação clínica publicados entre julho/2006 e julho/2016 nas línguas portuguesa, inglesa, espanhola e francesa, utilizando os termos MeSH: Folic Acid, Asthma e Pregnancy. Foi utilizada a escala SORT (Strength of Recommendation Taxonomy), da American Academy of Family Physicians, para atribuição do nível de evidência e forças de recomendação. Resultados: Foram selecionados cinco estudos de um total de 29 artigos encontrados: duas meta-análises e três estudos originais. As meta-análises não sustentam a associação entre a suplementação periconcecional com ácido fólico e o aumento do risco do desenvolvimento de asma na infância. No entanto, nenhum dos estudos incluídos nas meta-análises estratificam os resultados de acordo com a dose de ácido fólico fornecida à gestante durante a gestação e o risco de asma. Por outro lado, os estudos originais sugerem que a suplementação com altas doses de ácido fólico durante a gravidez pode aumentar o risco de desenvolvimento de asma na infância. Conclusões: A evidência da associação entre a suplementação com ácido fólico durante a gravidez e o risco de desenvolvimento de asma durante a infância é controversa. Os estudos com resultados estratificados por dose de ácido fólico mostraram que altas doses de suplementação (>800mg) estão associadas ao aumento do risco de desenvolvimento de asma na infância (SORT B).Associação Portuguesa de Medicina Geral e Familiar2018-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v34i2.12400https://doi.org/10.32385/rpmgf.v34i2.12400Portuguese Journal of Family Medicine and General Practice; Vol. 34 No. 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-95Revista Portuguesa de Medicina Geral e Familiar; Vol. 34 Núm. 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-95Revista Portuguesa de Medicina Geral e Familiar; Vol. 34 N.º 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-952182-51812182-517310.32385/rpmgf.v34i2reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/12400https://rpmgf.pt/ojs/index.php/rpmgf/article/view/12400/11424Direitos de Autor (c) 2018 Revista Portuguesa de Medicina Geral e Familiarinfo:eu-repo/semantics/openAccessRamôa, AndreiaCosta, PedroRibeiro, Ana MariaCastro, Stephanie De2024-09-17T12:00:13Zoai:ojs.rpmgf.pt:article/12400Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-09-17T12:00:13Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
Suplementação excessiva com ácido fólico durante a gravidez e desenvolvimento de asma na infância: uma revisão baseada na evidência
title Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
spellingShingle Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
Ramôa, Andreia
Folic acid
Asthma
Pregnancy
Ácido fólico
Asma
Gravidez
title_short Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
title_full Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
title_fullStr Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
title_full_unstemmed Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
title_sort Maternal high-dose folic acid during pregnancy and risk of asthma in children: an evidence based review
author Ramôa, Andreia
author_facet Ramôa, Andreia
Costa, Pedro
Ribeiro, Ana Maria
Castro, Stephanie De
author_role author
author2 Costa, Pedro
Ribeiro, Ana Maria
Castro, Stephanie De
author2_role author
author
author
dc.contributor.author.fl_str_mv Ramôa, Andreia
Costa, Pedro
Ribeiro, Ana Maria
Castro, Stephanie De
dc.subject.por.fl_str_mv Folic acid
Asthma
Pregnancy
Ácido fólico
Asma
Gravidez
topic Folic acid
Asthma
Pregnancy
Ácido fólico
Asma
Gravidez
description Objective: Maternal supplementation with folic acid has a positive effect on the prevention of neural tube defects. The relationship between high-dose supplementation of folic acid (5mg) and the development of asthma in children is controversial. The aim of this review is to appraise the evidence on the association between the supplementation with high doses of folic acid during pregnancy and the risk of developing asthma in childhood. Data sources: National Guideline Clearinghouse, Canadian Medical Association Practice Guidelines, Cochrane Library, DARE, Bandolier, PubMed and Index of Portuguese Medical Journals. Review method: We searched meta-analyses, systematic reviews, original studies and clinical guidelines published between July/2006 and July/2016 in Portuguese, English, Spanish and French languages, using the MeSH terms: ‘Folic Acid’, ‘Asthma’ and ‘Pregnancy’. The Strength of Recommendation Taxonomy (SORT) scale of the American of Family Physicians was used to assign evidence levels and strength of recommendation grades. Results: Five studies were selected from a total of 29 articles found, including two meta-analyses and three original studies. Results from meta-analyses do not support an association between periconceptional folic acid supplementation and increased risk of developing childhood asthma. However, none of the studies included in the meta-analyses stratified the results according to the dose of folic acid used during pregnancy and risk of asthma. On the other hand, original studies suggest that supplementation with high doses of folic acid during pregnancy may increase the risk of developing asthma in childhood. Conclusions: Evidence on the association between folic acid supplementation during pregnancy and the risk of developing asthma during childhood is controversial. Studies showing results stratified according to the dose of folic acid reveal that high doses (>800mg) are associated with an increased risk of developing childhood asthma (SORT B).
publishDate 2018
dc.date.none.fl_str_mv 2018-04-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.32385/rpmgf.v34i2.12400
https://doi.org/10.32385/rpmgf.v34i2.12400
url https://doi.org/10.32385/rpmgf.v34i2.12400
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rpmgf.pt/ojs/index.php/rpmgf/article/view/12400
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/12400/11424
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2018 Revista Portuguesa de Medicina Geral e Familiar
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2018 Revista Portuguesa de Medicina Geral e Familiar
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
dc.source.none.fl_str_mv Portuguese Journal of Family Medicine and General Practice; Vol. 34 No. 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-95
Revista Portuguesa de Medicina Geral e Familiar; Vol. 34 Núm. 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-95
Revista Portuguesa de Medicina Geral e Familiar; Vol. 34 N.º 2 (2018): Revista Portuguesa de Medicina Geral e Familiar; 89-95
2182-5181
2182-5173
10.32385/rpmgf.v34i2
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817547198112464896